skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

8 studies were found about valganciclovir

Valganciclovir to Reduce T Cell Activation in HIV Infection

Condition: HIV Infections; Cytomegalovirus Infections

NCT ID: NCT00264290

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Condition: Cytomegalovirus Infections; HIV Infections

NCT ID: NCT00006145

Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00017784

A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002222

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002377

History of the KSHV Inflammatory Cytokine Syndrome (KICS)

Condition: KSHV Inflammatory Cytokine Syndrome (KICS); KSHV; HHV-8

NCT ID: NCT01419561

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Condition: Giant Lymph Node Hyperplasia

NCT ID: NCT00092222

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Condition: Castleman Disease; Castleman's Disease; Giant Lymph Node Hyperplasia

NCT ID: NCT01441063